333 studies found for:
Open Studies | Interventional Studies | melanoma
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Efficacy of Nilotinib in First or Second Line Treatment of Primary Melanomas Stage III Unresectable Melanomas.
|
||||
2 | Not yet recruiting |
Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By Surgery
|
||||
3 | Recruiting |
LCCC 1128: Open Label Phase II Trial of the BRAF Inhibitor (Dabrafenib) and the MEK Inhibitor (Trametinib) in Unresectable Stage III and Stage IV BRAF Mutant Melanoma; Correlation of Resistance With the Kinome and Functional Mutations
|
||||
4 | Recruiting |
Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma
|
||||
5 | Recruiting |
Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma
|
||||
6 | Recruiting |
Dinaciclib in Treating Patients With Advanced Melanoma
|
||||
7 | Recruiting |
Axitinib in Treating Patients With Melanoma That is Metastatic or Cannot Be Removed By Surgery
|
||||
8 | Recruiting |
Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases
|
||||
9 | Recruiting |
Temozolomide or MEK Inhibitor AZD6244 in Treating Patients With Metastatic Melanoma of the Eye
|
||||
10 | Not yet recruiting |
Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma
|
||||
11 | Recruiting |
Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery
|
||||
12 | Recruiting |
Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery
|
||||
13 | Recruiting |
Imatinib Mesylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
|
||||
14 | Recruiting |
Aldesleukin With or Without Aflibercept in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
|
||||
15 | Not yet recruiting |
Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-Small Cell Lung Cancer, or Head and Neck Cancer
|
||||
16 | Recruiting |
Selumetinib and Akt Inhibitor MK2206 in Treating Patients With Stage III or Stage IV Melanoma Who Failed Prior Therapy With Vemurafenib or Dabrafenib
|
||||
17 | Recruiting |
Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
|
||||
18 | Recruiting |
Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma
|
||||
19 | Recruiting |
MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma
|
||||
20 | Recruiting |
Study of the Anti-Angiogenesis Agent Axitinib in Patients With Stage III Malignant Melanoma
|
† Indicates status has not been verified in more than two years